title: Identification of a CD28 response element in the CD40 ligand promoter.
abstract: Ligation of the T cell coreceptor CD28 or CD2 by its cognate ligands B7-1 or LFA-3, respectively, greatly aids the Ag-induced up-regulation of several genes, including IL-2 and CD40 ligand (CD40L). Using luciferase reporter constructs under the control of the 1.2 kb of 5' noncoding region of the human CD40L gene, we have found that stimulation through CD28 was required for a strong transcriptional activity of the CD40L promoter in response to TCR ligation, while the activity induced by CD2 was slightly lower than CD28. Deletion analysis demonstrated that the transcriptional elements mediating this effect were located within a 300-bp region upstream of the start site. Further dissection of this region and gel shift analyses demonstrated the presence of a CD28 response element in a region located between nucleotides -170 to -164 relative to the start site. Transcriptional studies with a CD40L enhancer-promoter carrying a mutation in this putative CD28 response element revealed that the activity was reduced by 80 and 70% after B7-1 and LFA-3 costimulation, respectively. The transcription factor complex bound to this site contained at least JunD, c-Fos, p50, p65, and c-REL:, but not c-Jun. Mutations introduced into the CD28RE also blocked the binding of this complex. These observations identify an important role for the CD28 signaling pathway in the regulation of CD40L promoter transcriptional activity.
authors.affiliation: Sidney Kimmel Cancer Center, San Diego, CA 92121, USA. eparra@skcc.org
authors.forename: E
authors.initials: E
authors.lastname: Parra
authors.forename: T
authors.initials: T
authors.lastname: Mustelin
authors.forename: M
authors.initials: M
authors.lastname: Dohlsten
authors.forename: D
authors.initials: D
authors.lastname: Mercola
mesh_terms: D000818:Animals; D018122:B7-1 Antigen / Q000502:physiology; D001482:Base Composition; D018106:CD28 Antigens / Q000235:genetics* / Q000276:immunology* / Q000378:metabolism; D023201:CD40 Ligand / Q000235:genetics* / Q000378:metabolism; D018968:CD58 Antigens / Q000502:physiology; D016466:CHO Cells; D006224:Cricetinae; D004268:DNA-Binding Proteins / Q000235:genetics; D005786:Gene Expression Regulation / Q000276:immunology; D006801:Humans; D019169:Jurkat Cells; D008213:Lymphocyte Activation / Q000235:genetics; D005810:Multigene Family / Q000276:immunology; D050778:NFATC Transcription Factors; D009687:Nuclear Proteins; D011401:Promoter Regions, Genetic / Q000276:immunology*; D016760:Proto-Oncogene Proteins c-fos / Q000378:metabolism; D016755:Proto-Oncogene Proteins c-jun / Q000378:metabolism; D020569:Proto-Oncogene Proteins c-rel / Q000378:metabolism; D020218:Response Elements / Q000276:immunology*; D014157:Transcription Factors / Q000235:genetics; D014158:Transcription, Genetic / Q000276:immunology
chemical_list: D018122:B7-1 Antigen; D018106:CD28 Antigens; D018968:CD58 Antigens; D004268:DNA-Binding Proteins; D050778:NFATC Transcription Factors; D009687:Nuclear Proteins; D016760:Proto-Oncogene Proteins c-fos; D016755:Proto-Oncogene Proteins c-jun; D020569:Proto-Oncogene Proteins c-rel; D014157:Transcription Factors; D023201:CD40 Ligand